J. Am. Chem. Soc. 2000, 122, 11031-11032
11031
or L-enantiomer at will, and adds a dimension of synthetic
flexibility inherent in the stannylvinyl R-branch.
Organoselenium-Based Entry into Versatile,
r-(2-Tributylstannyl)vinyl Amino Acids in Scalemic
Form: A New Route to Vinyl Stannanes
Scheme 1
David B. Berkowitz,* Jill M. McFadden, Esmort Chisowa, and
Craig L. Semerad
Department of Chemistry, UniVersity of Nebraska
Lincoln, Nebraska 68588-0304
ReceiVed August 4, 2000
Described herein is a synthetically malleable class of quater-
nary, R-(2-trialkylstannyl)vinyl amino acid (AA) building blocks
with potential applications in de noVo peptide design and
engineering. The stereocontrolled route to these AAs highlights
the versatility of the phenylseleno group, acting to (i) mask a
double bond, (ii) direct a low-temperature alkylation reaction, (iii)
facilitate an alkene unmasking step, and (iv) mediate the introduc-
tion of a stannylvinyl group through a new substitution reaction
that is expected to prove useful in other synthetic contexts.
In recent years, there has been heightened interest in R-branched
AAs, in general. As the free monomers, quaternary AAs bearing
â,γ-unsaturation are potential suicide inactivators for AA-
processing enzymes.1 When incorporated into peptides, quaternary
AAs can be used to promote R-helical,2 310-helical,3 or â-turn4
secondary structures. They may also be site-specifically engi-
neered into proteins.5 They are useful building blocks for natural
products6 or combinatorial libraries,7 and generally enhance the
proteolytic stability of their derivative peptides.8 For all such
applications, scalemic R-branched AAs are desirable.9-11 The
stereodivergent route detailed below allows one to access the D-
Our approach emanates from N-benzoyl-protected L-vinylgly-
cine12 and involves the installation of a directing â-stereocenter
in an episelenonium ion-mediated 5-exo-trig cyclization (Scheme
1). Readily separable by SiO2 chromatography, diastereomeric
oxazolines 2 and 3,13 serve as precursors to enantiomeric enolates,
each of which undergoes R-alkylation with essentially absolute
1,2-stereoinduction (Table 1). Thus, 2 and 3 may be regarded as
synthons for L- and D-higher vinyl AAs, respectively.
Interestingly, intermolecular R-alkylation effectively competes
with intramolecular expulsion of the â-amidate leaving group,
presumably for stereoelectronic reasons. That the alkyl halide
approaches the enolate exclusively anti to the â-(phenylseleno)-
methyl directing group was verified by independent synthesis of
both the anti (4a) and (hypothetical) syn (7a) BnBr-alkylation
products (Scheme 2). The alkylation reactions of 2 and 3 with
BnBr produce cleanly the anti alkylation products, L-4a and D-4a,
respectively. The syn alkylation product (7a) is absent (chiral
HPLC).
(1) Berkowitz, D. B.; Jahng, W.-J.; Pedersen, M. L. Bioorg. Med. Chem.
Lett. 1996, 6, 2151-2156; Elegant mechanistic work: Nanavati, S. M.;
Silverman, R. B. J. Am. Chem. Soc. 1991, 113, 9341-9349.
(2) (a) Schafmeister, C. E.; Po, J.; Verdine, G. L. J. Am. Chem. Soc. 2000,
122, 5891-5892. (b) Yokum, T. S.; Gauthier, T. J.; Hammer, R. P.;
McLaughlin, M. L. J. Am. Chem. Soc. 1997, 119, 1167-1168. (c) Altmann,
K.-H.; Altmann, E.; Mutter, M. HelV. Chim. Acta 1992, 75, 1198-1210. (d)
Karle, I.; Balaram, P. Biochemistry 1990, 29, 6747-6756.
(3) (a) Jaun, B.; Tanaka, M.; Seiler, P.; Ku¨hnle, F. N. M.; Braun, C.;
Seebach, D. Liebigs Ann./Recueil 1997, 1697-1710. (b) Aubry, A.; Bayeul,
D.; Pre´cigoux, G.; Pantano, M.; Formaggio, F.; Crisma, M.; Toniolo, C.;
Boesten, W. H. J.; Schoemaker, H. E.; Kamphuis, J. J. Chem. Soc., Perkin
Trans. 2 1994, 525-529.
(4) (a) Obrecht, D.; Altorfer, M.; Lehmann, C.; Schonholzer, Muller, K. J.
Org. Chem. 1996, 61, 4080-4086. (b) Wipf, P.; Hemgartner, H. HelV. Chim.
Acta 1988, 71, 258-267.
(5) (a) Mendel, D.; Ellman, J.; Schultz, P. G. J. Am. Chem. Soc. 1993,
115, 4359-4360. (b) See also: van Hest, J. C. M.; Kiick, K. L.; Tirrell, D.
A. J. Am. Chem. Soc. 2000, 122, 1282-1288.
(6) (a) Murray, W. V.; Sun, S.; Turchi, I. J.; Brown, F. K.; Gauthier, A. D.
J. Org. Chem. 1999, 64, 5930-5940. (b) Campbell, A. D.; Raynam, T. M.;
Taylor, R. J. K. Tetrahedron Lett. 1999, 40, 5263-5266. (c) Trost, B. M.;
Lemoine, R. C. ibid. 1996, 37, 9161-9164. (d) Huwe, C. M.; Blechert, S.
Ibid. 1995, 36, 1621-1624. (e) Krol, W. J.; Mao, S.; Steele, D. L.; Townsend,
C. A. J. Org. Chem. 1991, 56, 728-731. (f) Shaw, K. J.; Luly, J. R.; Rapoport,
H. J. Org. Chem. 1985, 50, 4515-4523.
Table 1. Stereocontrolled Side Chain Introduction/Alkene
Unmasking
(7) (a) Fornicola, R. S.; Oblinger, E.; Montgomery, J. J. Org. Chem. 1998,
63, 3528-3529. (b) Scott, W. L.; Zhou, C.; Fang, Z.; O’Donnell, M. J.
Tetrahedron Lett. 1997, 38, 3695-3698. (c) O’Donnell, M. J.; Zhou, C.; Scott,
W. L. J. Am. Chem. Soc. 1996, 118, 6070-6071. (d) Wenschuh, H.;
Beyermann, M.; Krause, E.; Brudel, M.; Winter, R.; Schu¨mann, M., Carpino,
L. A.; Bienert, M. J. Org. Chem. 1994, 59, 3275-3280.
(8) (a) Sall, D. J.; Shuman, R. T.; Smith, G. F.; Wiley: M. R. U.S. Patent
No. 5,484,772, July 16, 1996; (b) Frauer, A.; Mehlfu¨hrer, M.; Thirring, K.;
Berner, H.; J. Org. Chem. 1994, 59, 4215-4222. (c) Veber, D. F.; Freidinger,
R. M. Trends Neurosci. 1985, 8, 392-396. (d) Khosla, A.; Stachowiak, K.;
Smeby, R. R.; Bumpus, F. M.; Piriou, F.; Lintner, K.; Fermandjian, S. Proc.
Natl. Acad. Sci. U.S.A. 1981, 78, 757-760.
(9) Reviews: (a) Cativiela, C.; Diaz-de-Villegas, M. D. Tetrahedron:
Asymmetry 1998, 9, 3517-3599. (b) Davis. F. A.; Zhou, P.; Chen, B.-C. Chem.
Soc. ReV. 1998, 27, 13-18. (c) Wirth, T. Angew. Chem., Int. Ed. Engl. 1997,
36, 225-227. (d) Goodman, M.; Zhang, J. Chemtracts: Org. Chem. 1997,
10, 629-645. (e) Seebach, D.; Sting, A. R.; Hoffman, M. Angew. Chem., Int.
Ed. Engl. 1996, 35, 2708-2748. (f) Ojima, I. Acc. Chem. Res. 1995, 28, 383-
389. (g) Williams, R. M. Synthesis of Optically ActiVe Amino Acids; Pergamon
Press: Oxford, 1989.
alkyl unmask
starting
%
yieldb yieldb
oxazoline
alkyl halide
BnBr
BnBr
CH3I
CH3I
BnOCH2Br
EtO2CCH2Br
AA analogue
eea
(%)
(%)
2
3
2
3
2
2
2
2
Phe(L-4/5a)
Phe(D-4a)
Ala(L-4/5b)
Ala(D-4/5b)
Ser(L-4/5c)
Asp(L-4/5d)
99
>99
99
>99
99
99
90
80
82
79
80
86
90
78
76
---
77
71
80
74
75
---
ICH2C6H4-m-OTBS m-Tyr(L-4/5e)
98
E-PhCHdCHCH2Br Cinn-Gly(L-4f) >99
a ee’s are determined by chiral HPLC (Chiracel OD) vs racemic
standard for 4a-f. b Yields are of isolated, purified compounds.
10.1021/ja0055110 CCC: $19.00 © 2000 American Chemical Society
Published on Web 10/21/2000